510(k) K023857
K023857 is an FDA 510(k) premarket notification submitted by Bio-Rad for the device "PLATELIA ASPERGILLUS EIA, MODELS 62793 AND 62794". The FDA issued a decision of Substantially Equivalent on May 16, 2003. The device falls under product code NOM (Antigen, Galactomannan, Aspergillus Spp.), a Class I device regulated under 21 CFR 866.3040. Bio-Rad has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- May 16, 2003
- Date Received
- November 20, 2002
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Antigen, Galactomannan, Aspergillus Spp.
- Device Class
- Class I
- Regulation Number
- 866.3040
- Review Panel
- MI
- Submission Type
The Platelia Aspergillus EIA is an immunoenzymatic sandwich microplate assay for the detection of Aspergillus galactomannan antigen in human serum. It is a test which, when used in conjunction with other diagnostic procedures such as microbiological culture, histological examination of biopsy samples and radiographic evidence, can be used as an aid in the diagnosis of Invasive Aspergillosis.